DIGITAL THERAPIES (DTx)
Digital Therapies: Innovation in Healthcare
The power of evidence-based therapeutic tools backed by high-quality software programs
Today, digital therapeutic tools (DTx) have emerged as an innovative way to prevent, manage, and treat various medical diseases and disorders.
These solutions, backed by scientific evidence, use high-quality software programs to deliver effective and personalized therapies. With increasing financial pressures on healthcare systems, widespread adoption of DTx becomes crucial to ensure the sustainability of the system and improve patient health outcomes
FEATURES OF DTx
They can be used independently or as a complement to other devices and/or medications.
Digital therapies incorporate advanced technologies related to patient-centered design, artificial intelligence, and gamification. Additionally, they must meet strict criteria for interoperability and data privacy to ensure their proper functioning.
Certification by regulatory entities to ensure effectiveness, efficiency, and safety.
Digital therapies must be certified by regulatory entities to ensure their effectiveness, efficiency, and safety. These certification processes are essential to ensure that these solutions meet the necessary quality standards for clinical use.
Publication of results in peer-reviewed journals and randomized controlled trials (RCTs).
The results of clinical trials of digital therapies are published in peer-reviewed scientific journals. The gold standard for clinical trials used is the randomized controlled trial (RCT). These rigorous studies provide reliable scientific evidence on the efficacy and safety of these therapies.
Generation of real-world evidence to assess risks and benefits.
Digital therapies allow for the generation of real-world evidence through the capture and analysis of real-world data (RWD). These data are used to evaluate potential risks and benefits related to diseases and treatments. This information is valuable for improving the understanding of diseases and optimizing therapeutic approaches.
OUTSTANDING CHALLENGES
Market Access
Market access is one of the main challenges in the widespread adoption of digital therapies (DTx). Ensuring that these solutions are available to patients requires overcoming regulatory and administrative barriers.
Demonstrating Value
To promote the widespread adoption of DTx, it is necessary to demonstrate their value through a strong foundation of scientific evidence. This involves conducting rigorous clinical studies to evaluate the efficacy and safety of these therapies.
Business Model
Establishing a solid business model is another key challenge in the widespread adoption of digital therapies. It is necessary to strike a balance between accessibility for patients and the financial sustainability of these solutions.
Commercial Model
Close collaboration is required between healthcare providers, DTx developers, and decision-makers in healthcare systems.
BE PART OF OUR TEAM
WORK WITH US
We are an innovative laboratory that adds value to patients through the marketing of high-quality and trusted medications.
If you are passionate about this field and are looking to be part of a team committed to excellence, we invite you to join us.
AVANZIA PHARMA
CONTACT US